Suppr超能文献

展示中的人类大流行冠状病毒:刺突糖蛋白作为冠状病毒发挥作用的主角。

The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play.

机构信息

Department of Biochemistry and Molecular Biology, Federal University of Ceara, Brazil.

Drug research and Development Center, Department of Medicine, Federal University of Ceara, Brazil.

出版信息

Int J Biol Macromol. 2021 May 15;179:1-19. doi: 10.1016/j.ijbiomac.2021.02.203. Epub 2021 Mar 2.

Abstract

Three coronaviruses (CoVs) have threatened the world population by causing outbreaks in the last two decades. In late 2019, the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged and caused the coronaviruses to disease 2019 (COVID-19), leading to the ongoing global outbreak. The other pandemic coronaviruses, SARS-CoV and Middle East respiratory syndrome CoV (MERS-CoV), share a considerable level of similarities at genomic and protein levels. However, the differences between them lead to distinct behaviors. These differences result from the accumulation of mutations in the sequence and structure of spike (S) glycoprotein, which plays an essential role in coronavirus infection, pathogenicity, transmission, and evolution. In this review, we brought together many studies narrating a sequence of events and highlighting the differences among S proteins from SARS-CoV, MERS-CoV, and SARS-CoV-2. It was performed here, analysis of S protein sequences and structures from the three pandemic coronaviruses pointing out the mutations among them and what they come through. Additionally, we investigated the receptor-binding domain (RBD) from all S proteins explaining the mutation and biological importance of all of them. Finally, we discuss the mutation in the S protein from several new isolates of SARS-CoV-2, reporting their difference and importance. This review brings into detail how the variations in S protein that make SARS-CoV-2 more aggressive than its relatives coronaviruses and other differences between coronaviruses.

摘要

三种冠状病毒(CoVs)在过去二十年中通过引发疫情威胁着世界人口。2019 年末,严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)出现并导致冠状病毒病 2019(COVID-19),导致持续的全球爆发。其他大流行冠状病毒,严重急性呼吸综合征冠状病毒(SARS-CoV)和中东呼吸综合征冠状病毒(MERS-CoV),在基因组和蛋白质水平上具有相当程度的相似性。然而,它们之间的差异导致了不同的行为。这些差异源于刺突(S)糖蛋白序列和结构中突变的积累,刺突糖蛋白在冠状病毒感染、致病性、传播和进化中起着至关重要的作用。在这篇综述中,我们汇集了许多研究,讲述了一系列事件,并强调了 SARS-CoV、MERS-CoV 和 SARS-CoV-2 中 S 蛋白之间的差异。对来自三种大流行冠状病毒的 S 蛋白序列和结构进行了分析,指出了它们之间的突变以及它们所经历的变化。此外,我们研究了所有 S 蛋白的受体结合域(RBD),解释了它们的突变和生物学意义。最后,我们讨论了来自 SARS-CoV-2 的几个新分离株的 S 蛋白突变,报告了它们的差异和重要性。这篇综述详细介绍了 S 蛋白的变异如何使 SARS-CoV-2 比其亲缘冠状病毒更具攻击性,以及冠状病毒之间的其他差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/159f/7921731/47a8ae357dd1/gr1_lrg.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验